Patients experiencing adverse drug reactions (%) | 32 (21.19) |
Cumulative incidence (ADE/patient) | 0.23 |
Incidence density rate (ADE/1000 patient-days) | 15.45 |
Adverse drug events detected | 35 |
Drug-induced thrombocytopenia | 6 (17.14%) |
Piperacillin tazobactam | 3 (8.57%) |
Linezolid | 2 (5.71%) |
Heparin | 1 (2.85%) |
Nefrotoxicity | 17 (48.57%) |
Colistin | 16 (45.71) |
Apixaban | 1 (2.85%) |
Increase in liver enzymes | 3 (8.57%) |
Tigecycline | 2 (5.71%) |
Meropenem | 1 (2.85%) |
Electrolyte disorder (K + , Na +) | 6 (17.14%) |
Trimethoprim-sulfamethoxazole induced hyperkalemia | 3 (8.57%) |
Heparin induced hyponatremia | 1 (2.85%) |
Carbamazepine induced hyponatremia | 1 (2.85%) |
Escitalopram-induced hyponatremia | 1 (2.85%) |
Other | 3 (8.57%) |
Ciprofloxacin-associated seizures | 1 (2.85%) |
Midazolam over-sedation | 1 (2.85%) |
Metformin induced lactic acidosis | 1 (2.85%) |